Is Instil Bio Stock a Good Investment?
Instil Bio Investment Advice | TIL |
- Examine Instil Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Instil Bio's leadership team and their track record. Good management can help Instil Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Instil Bio's business and its evolving consumer preferences.
- Compare Instil Bio's performance and market position to its competitors. Analyze how Instil Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Instil Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Instil Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Instil Bio stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Instil Bio is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Instil Bio Stock
Researching Instil Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Instil Bio recorded a loss per share of 11.56. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 8th of December 2023.
To determine if Instil Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Instil Bio's research are outlined below:
| Instil Bio generated a negative expected return over the last 90 days | |
| Instil Bio has high historical volatility and very poor performance | |
| Instil Bio has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (156.09 M) with profit before taxes, overhead, and interest of 138 K. | |
| Instil Bio has about 354.61 M in cash with (82.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73. | |
| Instil Bio has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Instil Bio Announces Clinical Progress in China for IMM2510SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody |
Instil Bio Quarterly Long Term Debt |
|
Instil Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Instil Bio. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Instil Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Instil Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Instil Bio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-08-14 | 2023-06-30 | -0.16 | -0.14 | 0.02 | 12 | ||
2022-05-16 | 2022-03-31 | -0.38 | -0.42 | -0.04 | 10 | ||
2022-08-12 | 2022-06-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2022-03-07 | 2021-12-31 | -0.36 | -0.43 | -0.07 | 19 | ||
2021-08-12 | 2021-06-30 | -0.2 | -0.27 | -0.07 | 35 | ||
2021-05-13 | 2021-03-31 | -0.52 | -0.66 | -0.14 | 26 | ||
2023-03-31 | 2022-12-31 | -0.41 | -0.24 | 0.17 | 41 | ||
2023-05-11 | 2023-03-31 | -0.15 | -0.44 | -0.29 | 193 |
Instil Bio Target Price Consensus
Instil target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Instil Bio's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Instil analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Instil stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Instil Bio, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationInstil Bio Target Price Projection
Instil Bio's current and average target prices are 20.97 and 114.00, respectively. The current price of Instil Bio is the price at which Instil Bio is currently trading. On the other hand, Instil Bio's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Instil Bio Market Quote on 17th of January 2025
Target Price
Analyst Consensus On Instil Bio Target Price
Instil Bio Analyst Ratings
Instil Bio's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Instil Bio stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Instil Bio's financials, market performance, and future outlook by experienced professionals. Instil Bio's historical ratings below, therefore, can serve as a valuable tool for investors.Know Instil Bio's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Instil Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Instil Bio backward and forwards among themselves. Instil Bio's institutional investor refers to the entity that pools money to purchase Instil Bio's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Point72 Asset Management, L.p. | 2024-09-30 | 95.5 K | Blackrock Inc | 2024-09-30 | 52.8 K | Geode Capital Management, Llc | 2024-09-30 | 40.1 K | Orbimed Advisors, Llc | 2024-09-30 | 33.7 K | Vr Adviser, Llc | 2024-09-30 | 33.2 K | Fred Alger Management, Llc | 2024-09-30 | 31.3 K | Avidity Partners Management Lp | 2024-09-30 | 29.1 K | Adar1 Capital Management Llc | 2024-09-30 | 23.7 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 23.4 K | Vivo Capital, Llc | 2024-09-30 | 624.3 K | Cpmg Inc | 2024-09-30 | 410.9 K |
Instil Bio's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 139.78 M.Market Cap |
|
Instil Bio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.43) | (0.45) | |
| Return On Capital Employed | (0.26) | (0.27) | |
| Return On Assets | (0.43) | (0.45) | |
| Return On Equity | (0.79) | (0.76) |
Determining Instil Bio's profitability involves analyzing its financial statements and using various financial metrics to determine if Instil Bio is a good buy. For example, gross profit margin measures Instil Bio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Instil Bio's profitability and make more informed investment decisions.
Instil Bio's Earnings Breakdown by Geography
Evaluate Instil Bio's management efficiency
Instil Bio has Return on Asset of (0.1245) % which means that on every $100 spent on assets, it lost $0.1245. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.4865) %, meaning that it generated no profit with money invested by stockholders. Instil Bio's management efficiency ratios could be used to measure how well Instil Bio manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.45. The value of Return On Capital Employed is expected to slide to -0.27. At this time, Instil Bio's Total Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 670.4 M this year, although the value of Other Current Assets will most likely fall to about 8.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 31.25 | 27.15 | |
| Tangible Book Value Per Share | 31.25 | 26.36 | |
| Enterprise Value Over EBITDA | (0.78) | (0.82) | |
| Price Book Value Ratio | 0.20 | 0.21 | |
| Enterprise Value Multiple | (0.78) | (0.82) | |
| Price Fair Value | 0.20 | 0.21 | |
| Enterprise Value | 145.4 M | 138.1 M |
The operational strategies employed by Instil Bio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta 1.738 |
Basic technical analysis of Instil Stock
As of the 17th of January 2025, Instil Bio retains the Risk Adjusted Performance of (0.09), standard deviation of 6.72, and Market Risk Adjusted Performance of (0.81). Concerning fundamental indicators, the technical analysis model lets you check existing technical drivers of Instil Bio, as well as the relationship between them. Please check out Instil Bio market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Instil Bio is priced fairly, providing market reflects its last-minute price of 20.97 per share. Given that Instil Bio has information ratio of (0.12), we strongly advise you to confirm Instil Bio's regular market performance to make sure the company can sustain itself at a future point.Instil Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Instil Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Instil Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Instil Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Instil Bio's Outstanding Corporate Bonds
Instil Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Instil Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Instil bonds can be classified according to their maturity, which is the date when Instil Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US45782BAD64 Corp BondUS45782BAD64 | View | |
| Installed Building Products Corp BondUS45780RAA95 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand Instil Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Instil Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.81) | |||
| Mean Deviation | 5.45 | |||
| Coefficient Of Variation | (839.74) | |||
| Standard Deviation | 6.72 | |||
| Variance | 45.14 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.82) | |||
| Maximum Drawdown | 26.56 | |||
| Value At Risk | (9.64) | |||
| Potential Upside | 13.62 | |||
| Skewness | 0.7855 | |||
| Kurtosis | 0.0754 |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.81) | |||
| Mean Deviation | 5.45 | |||
| Coefficient Of Variation | (839.74) | |||
| Standard Deviation | 6.72 | |||
| Variance | 45.14 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (0.78) | |||
| Treynor Ratio | (0.82) | |||
| Maximum Drawdown | 26.56 | |||
| Value At Risk | (9.64) | |||
| Potential Upside | 13.62 | |||
| Skewness | 0.7855 | |||
| Kurtosis | 0.0754 |
Consider Instil Bio's intraday indicators
Instil Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Instil Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 1235.63 | |||
| Daily Balance Of Power | (0.62) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 20.99 | |||
| Day Typical Price | 20.98 | |||
| Price Action Indicator | (0.25) | |||
| Period Momentum Indicator | (0.45) |
Instil Bio Corporate Filings
8K | 14th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F3 | 22nd of October 2024 An amendment to the original Schedule 13D filing | ViewVerify |
13A | 27th of September 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Instil Stock media impact
Far too much social signal, news, headlines, and media speculation about Instil Bio that are available to investors today. That information is available publicly through Instil media outlets and privately through word of mouth or via Instil internal channels. However, regardless of the origin, that massive amount of Instil data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Instil Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Instil Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Instil Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Instil Bio alpha.
Instil Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Instil Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Instil Bio Corporate Management
| Sandeep MD | CFO Officer | Profile | |
| Timothy Moore | Chief Officer | Profile | |
| Bronson Crouch | Chairman CEO | Profile | |
| Sumita JD | Compliance, Legal | Profile | |
| Mark Dudley | Chief Officer | Profile | |
| Robert MBBS | Head Development | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Instil Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.